Erin O'Brien

Risk of suicide attempt is higher among adults, women.

Cohort includes professionals from multiple fields, including psychiatry and medicine.

Inaugural recipients will use funds to support infrastructure, student mental health, and programs for children with behavioral challenges.

Survey results addressed connections between migraine and mental health, stigma, and treatment preferences.

Study shows promising results for early detection and prevention efforts.

Did you miss the American Psychiatric Association 2022 Annual Meeting? We've got you covered.

Treatments alter the neural processes underlying SAD symptoms.

Interim study results show 77% treatment response rate among participants.

How can we help this unique patient population thrive? Experts weigh in at the 2022 APA Annual Meeting.

Experts discuss the role of motivation and willpower in ADHD at the 2022 APA Annual Meeting.

An expert discusses the effects of long COVID on the brain at the 2022 APA Annual Meeting.

Experts discuss appropriate interventions for patients who are victims of undue influence at the 2022 APA Annual Meeting.

Experts discuss psychiatry’s role in the advancement of AI technologies at the 2022 APA Annual Meeting.

The 2022 APA Annual Meeting highlights the latest guidelines for these treatments, plus recommendations for updates and improvements.

Experts address cognitive dysfunction found in patients with long COVID at the 2022 APA Annual Meeting.

How can we more effectively help patients with PTSD? Charles B. Nemeroff discusses the diagnosis, epidemiology, and pathophysiology of PTSD, along with current and emerging treatments, at the 2022 APA Annual Meeting.

Do classification systems make a difference? A presentation at the 2022 APA Annual Meeting noted 4 key diagnoses that differ significantly in the classification systems.

This year’s winner is a pioneer for the human rights of individuals with mental illness in West Africa.

Investigators observed higher levels of depression in children and adolescents with ADHD during MPH treatment.

Recommendations are often vague, contradictory, according to investigators.

Some of the more severe ADHD symptoms noted were depression/withdrawal, problems with socialization.

Top-line data for study is expected in late 2022, early 2023.

Physical activity, marital status among factors contributing to complete mental health among participants.

Approval comes 1 year after the drug was approved for the treatment of ADHD in children and adolescents.

Strategy highlights plans of action to address untreated addiction, overdose epidemic.

The most common issues during the COVID-19 pandemic included stress, anxiety.

Catch up on all the latest from the American Pharmacists Association (APhA) Annual Meeting & Exposition.

The warnings cite consumer risks, as well as FD&C, RHA violations.

Evidence review focuses on bipolar disorder, psychosis, and major depression.

In Season 5, the psychiatric community weighed in on everything from finding meaning in music to the importance of mindfulness.